300 Results (Page 2 of 12)
Indonesia Markets Research Reports
Indonesia Inhaled Nitric Oxide Market Analysis
Indonesia inhaled nitric oxide market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The factors driving the growth of this market are the rising prevalence of respiratory and other associated diseases and ongoing research and development activities. The key players in this market are Mallinckrodt, Linde plc., Air Liquide, BOC Limited, Bellerophon Therapeutics, Beyond Air Inc., Halma plc, VERO Biotech, Nu-Med Plus, Getinge AB, Merck KGaA, Genosys Informatics, Geno, and Perma Pure LLC.
Indonesia Interactive Wound Dressing Market Analysis
Indonesia interactive wound dressing market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Technology improvements, a growth in the prevalence of chronic wounds, and an increase in surgical procedures are the main factors driving the market for interactive wound dressings. Some of the key players in this market are Johnson & Johnson Medical N.V., Integra LifeSciences Corporation, B. Braun Melsungen AG, Cardinal Health, Medline Industries, Inc., Coloplast Pty Ltd, Medtronic, Beiersdorf AG, Mölnlycke Health Care AB, etc.
Indonesia Interferons Market Analysis
Indonesia interferons market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. It is anticipated that the development of novel drug delivery systems and the use of interferons in combination therapy will drive the market for interferons. The key players in this market are Roche, Merck & Co., Bristol-Myers Squibb, Biogen Inc., Bayer AG, Zydus Cadila, Novartis AG, Pfizer Inc., Biosidus, Synairgen, Nanogen, Amega Biotech, Rhein Minapharm Biogenetics.
Indonesia Interstitial Cystitis Drugs Market Analysis
Indonesia interstitial cystitis drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of interstitial cystitis and public knowledge of the ailment can be attributed for the market expansion. The key players in this market are Alvogen (CVC Capital Partners), Sandoz International GmbH (Novartis AG), Sun Pharmaceutical Industries Ltd., Accord Healthcare, Avet Pharmaceuticals Inc. (Heritage Pharmaceuticals Inc.), Lannett, Viatris Inc. (Pfizer Inc.), Reckitt Benckiser Group PLC, VistaPharm, Inc, Aurobindo Pharma, Prestige Consumer Healthcare Inc.
Indonesia Intravenous Solutions Market Analysis
Indonesia intravenous solutions market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rise in the prevalence of malnutrition, the quicker turnaround and higher efficacy associated with intravenous solution therapy, and the rise in the geriatric population all contribute to the growth of the intravenous solutions market. The key players in this market are Fresenius Kabi AG, Pfizer, Inc., Otsuka Pharmaceutical Co., Ltd., Baxter, B. Braun Melsungen AG, Vifor Pharma Management Ltd., JW Life Science, Amanta Healthcare, ICU Medical Inc., Grifols, S.A.
Indonesia Irritable Bowel Syndrome Drugs Market Analysis
Indonesia irritable bowel syndrome drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increased illness awareness, the expected timely availability of recently approved drugs, an enhanced payment system, and rising IBS prevalence are the main market drivers for IBS-D pharmaceuticals. The key players in this market are Allergan, Ironwood Pharmaceuticals, Inc., Synergy Pharmaceuticals Inc., Bausch Health, Takeda Pharmaceutical Company Limited, AstraZeneca, Sebela Pharmaceuticals Inc., Synthetic Biologics, Inc., Astellas Pharma, Inc., and Ardelyx.
Indonesia Isoflavones Market Analysis
Indonesia isoflavones drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is primarily driven by three factors: the growing elderly population, technological developments in the production of isoflavones, and the rising prevalence of cancer and other chronic disorders. The major key players in this market are Cargill, BASF, DSM, Shanghai Freemen, and ADM. Other key players include Nexira Inc., Bio-gen Extracts, Sikko Industries, SK Bioland, BioMax, Avestia Pharma, NutraScience Labs, Tradichem S.L., Nutra Green Biotechnology.
Indonesia Kidney Cancer Drugs Market Analysis
Indonesia kidney cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rising consumer awareness, technical improvements, and the appeal of kidney and renal cancer drugs goods are all contributing reasons to the market's expansion. Some of the major key players in this market are Pfizer Inc (US), AstraZeneca (UK), Bristol-Myers Squibb Company (US), Dr. Reddy's Laboratories Ltd (India), Endo International plc (Ireland), etc.
Indonesia Knee Cartilage Repair Market Analysis
Indonesia knee cartilage repair market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Major factors contributing to the growth of the global knee cartilage repair market include the area's steadily expanding geriatric population, as well as the rising prevalence of different orthopaedic conditions, neuromuscular disorders, sports injuries, and musculoskeletal diseases. The major key players in this market are B. Braun Melsungen AG, Histogenics Corporation, ISTO Biologics, Inc., Johnson & Johnson (DePuy Synthes), MEDIPOST Co., Ltd., Smith & Nephew plc (Osiris Therapeutics, Inc.), Stryker Corporation, Takeda Pharmaceutical Co. Ltd. (TiGenix N.V.), Vericel Corporation, and Zimmer Biomet.
Indonesia Lactoferrin Market Analysis
Indonesia lactoferrin market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Technology advances that enable effective operational maintenance, efficient production, an extended product line, elegant design and packaging, and sales monitoring are key growth factors for the lactoferrin industry. The major key players in this market are Hilmar Cheese Company, Pharming Group NV, FrieslandCamina, Synlait Milk Ltd., Ingredia SA, MP Biomedicals, Tatura Milk Industries Ltd., Glanbia plc, APS BioGroup, ProHealth, Fonterra Cooperative Group Ltd., Farbest Brands, InVitria, Milei GmbH, Ferrin-tech LLC.
Indonesia Lipid Lowering Drugs Market Analysis
Indonesia lipid lowering drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increase in heart disease cases, higher awareness of the health risks associated with high cholesterol levels, and the availability of effective treatments are key factors driving the global market for lipid-lowering pharmaceuticals. The major key players in this market are Sanofi, Sun Pharmaceutical Industries Ltd., AstraZeneca, Pfizer Inc., Novartis AG, AbbVie Inc., Merck & Co. Inc., Amgen Inc., and Dr. Reddy's.
Indonesia Liver Cancer Drugs Market Analysis
Indonesia liver cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising incidence of liver cancer and the accessibility of novel medications are the two main drivers of market expansion over the forecast period. In the upcoming years, market expansion is anticipated to be fueled by increased investments in the research & development industry and the discovery of novel medicines. The major key players in this market are Bayer HealthCare Pharmaceuticals Inc. (Germany), Bristol-Myers & Squibb Company (US), Pfizer Inc. (US), Exelixis, Inc. (US), Merck Sharp & Dohme Corp. (US), Eisai Inc. (Japan), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland).
Indonesia Mammography Device Market Analysis
Indonesia mammography device market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The demand for mammography equipment is influenced by early cancer detection, cancer fear, and quality of life after a diagnosis. The major key players in this market are Hologic Inc., Analogic Corporation, Canon Medical Systems Corporation, Fujifilm Corporation, Siemens Healthcare, Toshiba Medical Systems, GE Healthcare, Metaltronica, Koninklijke Philips N.V., Planmed Oy.
Indonesia Medical Cannabis Drugs Market Analysis
Indonesia medical cannabis drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Globally, there are more people with chronic illnesses, which will probably result in an increase in patients, and people are becoming more interested in living healthy lives. Additionally, it's projected that a rise in product approvals and increased R&D for cannabis-related medical devices will fuel market growth. The major key players in this market are Tilray, Bedrocan International, Canopy Growth Corporation, Aurora Cannabis Inc., Vivo Cannabis Inc., Maricann Inc., Medical Marijuana Inc., Organigram Holdings Inc., The Scotts Company LLC, Curaleaf Holdings, Inc.
Indonesia Medical Electronics Market Analysis
Indonesia medical electronics market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing incidence and prevalence of chronic diseases, the growing elderly population, and the expanding use of machine vision are the few factors that will affect medical electronic market. The increased incidence of chronic diseases like cancer, neurological diseases, cardiovascular diseases, respiratory diseases, and others is the main factor driving market expansion. Some of the major key players in this market are Analog Devices, Inc., Texas Instruments Incorporated., Medtronic, STMicroelectronics, Mouser Electronics, Inc., etc.
Indonesia Medical Imaging Market Analysis
Indonesia medical imaging market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Teaching hospitals and universities are projected to need more modern imaging modalities in order to train students in cutting-edge technology, which is anticipated to have a significant impact on market growth. The major key players in this market are GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Canon Medical Systems Corp., Mindray Medical International, Esaote, Hologic, Inc., Samsung Medison Co., Ltd., Koning Corporation, PerkinElmer Inc., FUJIFILM VisualSonics Inc., Cubresa Inc.
Indonesia Medical Information Market Analysis
Indonesia medical information market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is anticipated to grow due to the increase in demand for the creation of new drugs, the creation of technologically advanced healthcare solutions, and the ease with which information about healthcare products can be accessed. The major key players in this market are Accenture Plc, Change Healthcare Inc., Cognizant Technology Solutions Corp., Ergomed Plc, HCL Technologies Ltd., Infosys Ltd., IQVIA Holdings Inc., MakroCare, Parexel International Corp., ProPharma Group Holdings LLC.
Indonesia Medical X-ray Market Analysis
Indonesia medical X-ray market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. One of the key factors driving the expansion of the medical X-ray market is the rising incidence of bone fractures. Other indirect market growth factors include increased personal disposable income, increasing rates of traffic accidents, and rising costs for R&D operations. Some of the major key players in this market are General Electric Co., Toshiba Corporation, Koninklijke Philips N.V., Carestream Health., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., etc.
Indonesia Melanoma Drugs Market Analysis
Indonesia melanoma drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. This market is growing as a result of factors like an increase in melanoma incidence, greater awareness of available melanoma diagnostic and treatment options, and technological advancements in melanoma drugs. The major key players in this market are Novartis, Roche Holding AG, GlaxoSmithKline, Pfizer, Merck Group, Bristol Myers Squibb (BMY), Amgen, Genentech, Eisai Co. Ltd, Janssen Biotech, BeiGene Ltd, Iovance Biotherapeutics Inc., AB Science, Grand Pharmaceutical Group Co., Ltd. and, Navidea Biopharmaceuticals.
Indonesia Meningococcal Vaccines Market Analysis
Indonesia meningococcal vaccines market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing incidence of meningococcal disease among young children and adolescents globally is one of the key factors driving the market's rise. Additionally, market expansion is being fueled by the acceptance of routine vaccinations and an overall rise in health consciousness. The major key players in this market are GlaxoSmithKline Plc, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Limited, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Ltd. and Walvax Biotechnology Co. Ltd.
Indonesia Metabolic Disorder Drugs Market Analysis
Indonesia metabolic disorder drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The ageing population, rising diabetes and obesity rates, and the prevalence of metabolic disorders are all driving factors for the global market for medications treating these conditions. Another element fueling the expansion of this market is an increase in public awareness of various ailments and associated pharmacological treatments. Some of the major key players in this market are AbbVie, Actelion Pharmaceuticals, Amgen, Astra Zeneca, Biocon, BioMarin Pharmaceutical, etc.
Indonesia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Analysis
Indonesia Methicillin-resistant Staphylococcus Aureus (MRSA) drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rise in governmental and private financing for research and development of novel anti-MRSA medications as well as their improved screening are the main drivers of the growth of the market for treating methicillin-resistant staphylococcus aureus (MRSA). Some of the major key players in this market are Merck & Co., Inc., Pfizer Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Melinta Therapeutics, Inc., etc.
Indonesia Microspheres Market Analysis
Indonesia microspheres market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Medical science and technology improvements as well as rising usage in the medical business are the main drivers of the market under study. The key players in this market are Nouryon Chemicals Holding B.V., Trelleborg AB, Chase Corporation, Mo SCI Corporation, 3M Co., and Kureha Corporation.
Indonesia Migraine Drugs Market Analysis
Indonesia migraine drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. High alcohol consumption, rising healthcare costs, rising job stress, and rising medicine demand are all expected to drive market expansion. In the years ahead, it is anticipated that there will be a rise in public knowledge of migraines and available treatments which will further act as a driver for Migraine Drugs Market. The major key players in this market are Amgen, Abbott Laboratories, Allergan, Eli Lilly, Pfizer, Inc., AstraZeneca, Johnson and Johnson Services, Inc., and GlaxoSmithKline.
Indonesia Multiple Myeloma Drugs Market Analysis
Indonesia multiple myeloma drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased prevalence of the illness, new technologies, and improved healthcare systems are a few of the elements boosting the revenue of the worldwide multiple myeloma market. The major key players in this market are Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Genentech Inc. (F. Hoffmann-La Roche Ltd), Novartis AG, etc.